ask="3.44"
ask_size="1000"
average_daily_volume="172665"
bid="2.11"
bid_size="400"
book_value="1.35"
change="-0.10"
change_from_200_day_moving_average="-2.44"
change_from_50_day_moving_average="0.04"
change_from_52_week_high="-7.27"
change_From_52_week_low="0.90"
change_in_percent="-4.15%"
close="2.31"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.32"
ebitda="0.00"
eps_estimate_current_year="-0.32"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.34"
ex_dividend_date="N/A"
float_shares="N/A"
high="2.38"
high_52_weeks="9.58"
last_trade_date="1/13/2017"
last_trade_price="2.31"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.30"
low_52_weeks="1.41"
market_capitalization="27.84M"
moving_average_200_day="4.75"
moving_average_50_day="2.27"
name="Moleculin Biotech
Inc."
notes="N/A"
one_year_target_price="9.26"
open="2.37"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-51.38%"
percent_change_from_50_day_moving_average="+1.65%"
percent_change_from_52_week_high="-75.89%"
percent_change_from_52_week_low="+64.06%"
previous_close="2.41"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.79"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="12054000"
short_ratio="1.38"
stock_exchange="NCM"
symbol="MBRX"
volume="25916"
weeks_range_52="1.41 - 9.58"
